You are on page 1of 64

CHAPTER 1 : ABOUT THE NIRLIFE HEALTH CARE

Nirlife is the brand of the healthcare division of well-diversified FMCG Major- Nirma Limited. Being in the healthcare domain Nirlife assumes great sense of responsibility and wholeheartedly concentrates on better value delivery with uncompromising quality, guaranteed efficiency, and continuous innovation.

1) HISTORY: Established in 1969, Nirma has earned a strong presence in millions of households within as well as beyond Indian frontiers. And today this name spells unparalleled growth and absolute reliability, with a market leader position in one of the largest economy. Nirma keenly extends this success story into the healthcare domain under Nirlife brand. After all, health is happiness. Nirlife Healthcare is one of the largest manufacturer and marketer of extensive range of parenteral products and medical devices in the global market. With a strong research oriented work culture, state-of-the-art production facility and end-toend product development capabilities - Nirlife is comfortably poised to establish itself as a leading healthcare brand in the international and domestic market. The manufacturing facility is WHO GMP, CE and ISO certified. The set-up is equipped with quality systems and processes to adhere stringent evaluation parameters and to sustain growth through innovation, R&D and state-of-art analytical infrastructure in healthcare segment. Nirlife brand is established with a vision to attain significant presence in healthcare segment globally through cost effectiveness, innovation and quality healthy life to the end-user...
1

Nirlife manufactures "Oneuse" range of medical devices In a fully integrated and automated state-of-the-art Facility. This facility includes compounding of plastic, moulding of components, assembling of components and packaging of medical devices, all under one roof.

1.1) Belief:

VISION, MISSION, BELIEF, VALUE:

Health is Happiness Vision: To be a leading player in the field of healthcare by manufacturing and supplying high quality healthcare products and thus contribute to the well being of humankind and offering health and thus Happiness. Mission: To provide high quality healthcare products to masses at affordable price. Values:

Continuous exploration & development of new products & processes Laying emphasis on cost effectiveness Maintaining effective Quality Management System Complying with safety, environment and social obligations Imparting training to all involved on a continuous basis Team work and active participation all around
2

1.2)

EXPERTISE / OPERATIONS :

With four multi therapy divisions Nirlife is leading player in the Healthcare industry in India.We are leader in Intravenous infusions, Parenteral Anti-infective, Small volume parenterals and Medical disposable devices. In specialty therapy, like Anesthesia, Plasma Expander, Total Parenteral Nutrition, Blood products, we are aiming to be a leader by 2011. Under disposable medical devices, we at Nirlife have Oneuse range of disposables includes syringe, needle, Infusion sets, Micro drip set, Alcoholic swab etc. We are enjoying 50% market share in disposable devices. We have forayed into manufacturing of pharmaceuticals in liquid, solid, powder, semi-solid dosage forms as well as in novel drug delivery systems. State of the art manufacturing facility We have adopted state of the art technology and equipments from world majors. This gives us edge over others in terms of our offering quality products to our valued customers. We at Nirlife, believes in Health is Happiness and thus involved in providing quality healthcare products to masses and thus offering helping hand to Medical professionals in their noble cause of saving life and offering Health to mankind

Nirlife a healthcare division of

Nirma Limited acquired 20 years old manufacturing

facility.This is our 1st step in healthcare segment with parenteral preparation.

Today, Nirlife has large operational capabilities to produce and market over 250 million bottles of Large Volume Parenteral, 1300 million ampoules of Small Volume Parenteral and 1500 million units of Medical Devices - perhaps one of the largest capacities in the global marketplace. The production base is located at Sachana village, in vicinity of Ahmedabad, Gujarat, India. Nirlife has world class technology at Sachana near Viramgam, 55 km away from Ahmedabad. At present Nirlife became market leader within a short span of 3 years and Nirlife became Indias largest manufacturer in parenteral preparations and beat the giants through marketing Large Volume Parenteral (LVP), Small Volume Parenteral (SVP), High-end Parenteral Nutrition products, Medical Devices and consumer healthcare products.

1.3)

PRODUCTS :

Mainly 4 category of product are there namely as: MDD (medical disposable devices) SVP (small volume parentaral) CCD (critical care devices) LVP (large volume parentaral)

PRODUCT 1 : MDD (medical disposable devices) Oneuse Disposable Medical Devices Sr. No. 1 2

Brand Name Oneuse Syringe Oneuse Syringe

Product Name 2 pc syringe 3 pc syringe

Volume/ Size / SKU 2, 5, 10 ml 2, 3, 5 ml

Packing Blister pack (100/ pack) Ribbon pack (100/ pack)


4

3 4

Oneuse Needle Oneuse Infusion set Oneuse Alcoholic Swab

Needle With / Without airvent Alcohol swab

18 G to 28 G

Blister pack (100/ pack) Blister / Ribbon pack (50/ pack)

Sachet (100 / pack)

6 7 8

Oneuse Blood Blood Transfer set Transfer set Oneuse Insulin syringe Oneuse Microdrip set Oneuse Measured volume set Oneuse Surgical gloves Oneuse Adult Diper Insulin syringe 30G , 31 G Micro drip set Measured volume set Surgical gloves Adult diper 6.5', 7.0', 7.5' Medium, Large, Extra large 30G, 31 G

Ribbon pack (25/ pack) Ribbon pack (10/ pack) Ribbon pack (25/ pack)

Ribbon pack (10/ pack)

10 11

Plastic bag (5 / bag and 10/ bag)

PRODUCT 2 : SVP (small volume parentaral) Anti-infective Brand Name Nircip Nirget Nirliv Nirflox

Sr. No. 1 2 3 4

Product Name Ciprofloxacin Injections Gatifloxacin Injections Levofloxacin Injections Ofloxacin Injections

Volume 100 ml 200 ml 100 ml 100 ml, 200 ml

Container Nipple Head / Euro Head Nipple Head / Euro Head Nipple Head / Euro Head Nipple Head / Euro Head

5 6 7 8

Nirmet Nirzolid Nirmet plus Flucanir

Metronidazole Injections Linezolid Injections Metronidazole with Dextrose Fluconazole Injection

100 ml 100 ml, 300 ml 500 ml 100 ml

Nipple Head / Euro Head Nipple Head / Euro Head Nipple Head / Euro Head Glass bottle

Diluents Sr. No. 1 2 3 4 Brand Name SWFI NS 30D 50D Product Name Sterile Water for Injection Sodium chloride Injection 30% Dextrose 50% Dextrose Volume 5 , 10, 20 ml 5, 10 ml 20 ml 20 ml Container Plastic ampoule Plastic ampoule Plastic ampoule Plastic ampoule

Respules

Sr. No. 1 2

Brand Name Salbutamol Levosalbutamol

Product Name Salbutamol Levosalbutamol

Volume 2.5 ml 2.5 ml

Container Plastic ampoule Plastic ampoule

PRODUCT 3 : CCD (critical care devices) specialty products Sr. No. 1 2 3 4 5 6 Brand Name Meronir Iminir Meronir kit Iminir Kit Pipranir kit Cefonir kit Product Name Meropenem Injection Imipenem Injection Meropenem injection + NS 100 ml + IV set Imipenem injection +NS 100 ml + IV set Pipracillin + Tazobactum + NS 100 ml + IV Set Cefoperazone +Sulbactum + NS 100 ml+ IV set Volume 500 mg, 1 gm 500 mg 1 gm 500 mg 4.5 gm 1 gm Container Glass vial Glass vial Glass vial Glass vial Kit Kit

Anesthetic range of products Sr. No. 1 2 3 4 5 6 Brand Name Nirfol Lignonir Lignonir ADR Ketanir Midanir Thionir Product Name Volume Container Glass bottle Glass vial Glass vial Glass vial Glass amp, Vial Glass vial
7

Propofol Intravenous 10, 20, 50, 100 Injection ml Lignocaine injection 2% Lignocaine Injection with Adrenaline 2% Ketamin Injection (50 mg/ ml) Midazolam Injection Thiopentone sodium 30 ml 30 ml 10 ml 5 ml, 10 ml 500 mg, 1000 mg

7 8 9 10

Stignir Atranir Vecurnir Rocunir

Neostigmine Injection Atracurium injection Vecuronium injection Rocuronium injection

1 ml, 5 ml 2.5, 5 , 10 ml 2, 10 mg 5 ml

Ampoule Ampoule Glass vial Glass vial

Plasma Volume Expander Sr. No. 1 2 3 Brand Name Nirhes - 200 Nirhes - 130 Nirtran Product Name Hydroxy Ethyl Starch (200/0.5) - 6% Hydroxy Ethyl Starch (130/0.4) - 6% Dextran IV infusion Volume 500 ml 500 ml 500 ml Container Plastic bottle Bag Plastic bottle

Blood and related products Sr. No. 1 2 3 4 Brand Name Eponir IVIG Sucronir Hepanir Product Name Erythropoietin injection Intravenous Immunoglobulin G Iron Sucrose Injection Heparin Injection Volume 2000 iu, 4000 iu 100 ml 5 ml 5000 iu, 25000 iu Container PFS Glass bottle Glass ampoule Glass vial

PRODUCT 4: LVP (large volume parentaral) Dextrose containing products

Sr. No. 1

Brand Name 5D

Product Name 5% Dextrose

Volume

Container

100 / 250 / 500 Nipple Head / Euro / 1000 ml Head/ Bag 100 / 250 / 500 Nipple Head / Euro / 1000 ml Head/ Bag 100 / 250 / 500 Nipple Head / Euro / 1000 ml Head/ Bag 100 / 250 / 500 Nipple Head / Euro / 1000 ml Head/ Bag 100 / 250 / 500 Nipple Head / Euro / 1000 ml Head/ Bag

10 D

10% Dextrose

20 D

20% Dextrose

25 D

25% Dextreose

50 D

50% Dextrose

Uretics Sr. No. 1 2 Brand Name 20 M Nirtol G Product Name 20% Mannitol Mannitol with Glycerin Volume 100 ml, 350 ml 100 ML Container Nipple Head / Euro Head Nipple Head / Euro Head

Dialysis solution Sr. No. 1 Brand Name PD Product Name Peritoneal Dialysis solution Volume 2 lit, 3 lit Container Bags

Other Sr. No. 1 Brand Name Fructonir Product Name 10% Invert Sugar Invert Sugar with NS Volume 500 ml Container Nipple Head / Euro Head Nipple Head / Euro Head

Fructonir NS

500 ml

10

CHAPTER 2 : INTRODUCTION TO TOPIC

2.1) MARKET SHARE : Market share is one of the primary indicators companies use to measure how well they are doing versus competitors. Market share is defined as The percentage of business or product or sales a company wields out of total business or product or sales by all competitors combined in any given market respectively. The total available business is called market potential. There are two basic ways of stating market share figures 1) Percent of Sales 2) Percent of Units 3) Questionnaire fill

2.1.1) PERCENT OF SALES : Percent of sales is one measure of market share. For example, if a small electronics firm sells $2 million in a market with a total of $100 million in sales, its market share is 2 percent. That is just one market, however. Imagine that the small electronics firm sells products in 10 markets -- with market share figures varying between 1 percent and 4 percent in each market. The firm's total market share for all 10 markets might be 2.5 percent. 2.1.2) PERCENT OF UNITS : Companies can calculate market share using sales units. For example, a small bottled-water distributor may sell 10,000 units per year out of the 100,000 sold in a local market area by all competitors combined. Therefore, its market share is 10 percent for that market. Unit market share may be more useful in some cases, as companies can better derive average product prices of competitors. They can use this information to better price their own products.
11

2.1.3) QUESTIONNAIRE FILL : Questionnaire fill up, which is used most often by researchers, is based on a series of competitive interviews and/or question where each respondent is asked for certine question related to product and/or business and from that market share would be determined. 2.2) MDD PRODUCTS OF NIRLIFE HEALTH CARE : MDD means medical disposable devices. It includes 1) Syringe and Needle 3) IV set 4) Diper 2.2.1) SYRINGE AND NEEDLE : A syringe is a simple pump consisting of a plunger that fits tightly in a tube. The plunger can be pulled and pushed along inside a cylindrical tube (called a barrel), allowing the syringe to take in and expel a liquid or gas through an orifice at the open end of the tube. The open end of the syringe may be fitted with a hypodermic needle.

TABLE 2.2.1.1) A DIAGRAM OF SYRINGE


12

CHART 2.2.1.1) A DIAGRAM OF NEEDLE SHAPES

TABLE 2.2.1.2) COLOUR WITH SIZE OF NEEDLE

13

VARIABLE THAT AFFECT SYRINGE AND NEEDLES MARKET SHARE : Quality of gradution mark Tranaparency of barrel Smoothness of pluger Leakage Gasket material Size availability Price Needle bevel availability Colour availability Pain Gauge size availability

2.2.2) IV SET : it is intravenous set mainly used for the continuous introduction of a solution intravenously , a drop at a time. venous means vein and Intravenous (IV) medications are a solutions administered directly into the venous circulation via a syringe or intravenous catheter (tube). The device used to administer an intravenous solution, such as the familiar IV drip. IV CATHETER : Intravenous catheters are used for administration of medication and fluids directly into your veins. They are usually located in your hand, arm, or neck. It contains a small needle with a hollow tube inserted into a vein and used to give medicines or fluids. It refers to the placement of a small, flexible, tubular instrument that is passed into a vein (typically in the forelimb) and secured there to provide a port that allows delivery of fluids, nutrition, or blood products directly into the bloodstream.
14

VARIABLE THAT AFFECT IV SETS MARKET SHARE : Price Quality of material Tip Traperancy of tube

DIAGRAM OF IV SET AND IV CATHETER

15

TABLE 2.2.2.1) CATHETER WITH COLOUR AND SIZE

2.23) ADULT DIAPER : An adult diaper (or adult nappy) is a diaper made to be worn by a person with a body larger than that of an infant or toddler. Diapers can be necessary for adults with various conditions, such as incontinence, mobility impairment, severe diarrhea or dementia. Adult diapers are made in various forms, including those resembling traditional child

diapers, underpants, and pads resemblingsanitary napkins (known as incontinence pads).

16

VARIABLE THAT AFFECT DIAPERS MARKET SHARE : Price Material Elasticity Comfortness Size availability

17

CHAPTER 3 : LITERATURE REVIEW

3.1) According to study conducted by An IndiaCLEN Programme Evaluation Network Study (IPEN Study) on Assessment of injection practices in India in partnership with Ministry of Health and Family Welfare, Government Of India, World bank , Medical injections administered in India per year add up to 4.5 billion (the approximate annual demand in Indian market) . Aggregate demand of syringes in the states Gujarat, Maharashtra, Andhra Pradesh, Karnataka and Tamilnadu account for around 45% of total annual demand in India. 62% i.e. 3.1 billionof these injections are unsafe. In India around 0.3 million people die each year because of being administered unsafe injections (according to World Health Organisation, WHO).

3.2) According to Netscribes (India) Pvt. Ltd and Dublin Research and Market has announced "Syringes And Needles Market in India 2011" report , as Growing Insulin and Vaccine Needs Driving the Syringes & Needles Market in India, finds Netscribes The Indian syringes & needles market is growing steadily owing to the better healthcare facilities arising from the improved infrastructure. An analysis of the drivers explains the factors leading to the growth of the market which include increasing need of insulin doses, increasing demand for vaccines, improving health infrastructure, growing incidence of diseases, changing demographics and health check-up packages. Some of the major challenges to the market are illegal recycling of syringes & needles and problems associated with usage.

18

CHAPTER 4 : RESERCH METHODOLOGY

4.1) THE RESEARCH PROCESS : The Marketing research process involves a number of interrelated activities which dont rigidly follow a particular sequence. Followings are the various steps in the research methodology process: 1) Formulating the research problem. 2) Choice of research design. 3) Determining sources of data. 4) Designing data collection forms. 5) Determining sampling design and sampling size. 6) Organizing and conducting the field survey. 7) Processing and analyzing the collected data. 8) Preparing the research report.

4.2) NEED FOR THE STUDY: Nirlife healthcare wants to know the market share and market presence of MDD products so that whether they increase sales or not. Nirlife healthcare wants to know the local and branded leader in the market of syringe and needle, iv set and diaper

19

4.3) RESERCH TOPIC : In-depth study of market share and market presence of MDD product with reference to nirlife health care pvt ltd.

4.4) RESERCH OBJECTIVE : 1) To find out MDD products market share and market presence of Nirlife health care pvt ltd. 2) To find out different Syringe and Needle, iv set, Diaper available in the market. 3) To identify variable that affect the market share of MDD product of Nirlife health care pvt ltd.

4.5) RESERCH QUESTION : 1) How to measure the market share market presence of Nirlife health care pvt ltd? 2) What are the different Syringe and Needle, iv set, Diaper available in the market? 3) What are the different variable that affect market share of MDD product of Nirlife health care pvt ltd? 4.6) HYPOTHESIS : H0 : There is association between preference of Syringe/Needle and consumption of

Syringe/Needle. H1 : There is association between preference of IV set and consumption of IV set. H2 : There is association between preference of Diaper and consumption of Diaper. H3: There is association between preference of syringe/Needle and consumption of syringe/Needle.

20

4.7) RESEARCH DESIGN : It is a frame work or blue print for conducting the marketing research project. It is a frame it specifies the details of the procedures necessary for obtaining the information needed to structure and solve marketing research problems. A research design lays the foundation for conducting the project. A good research design will ensure that the marketing research project is conducted effectively and efficiently. Typically a research design involves the following tasks: 1) Design exploratory, conclusive and or descriptive phase of the project. 2) Define the information needed. 3) Specify the measurement and scaling procedure. 4) Construct and present an appropriate form of data collection. 5) Specify the sampling process and sample size. 6) Develop a plan for data analysis. The research design was conducted in two phases. 1) Exploratory Research 2) Conclusive Research 4.7.1) Exploratory Research : It is a type of research design, which has its primary objective of getting an insight into and understanding of the problem situation confronting the researcher. It has been conducted using secondary data & qualitative research. Secondary data: 1. External: Published material Computerized database

21

4.7.2) Conclusive Research : Descriptive research : It is a type of conclusive research that has its major objective the description of something usually market characteristics or functions. Descriptive research is preplanned and structured. It is based on large amount of representative samples. For the descriptive research I have used the survey method in which single cross sectional design has been adopted. 1) Survey method Cross sectional design single cross sectional Single cross sectional : It is a cross sectional design in which one sample of respondents is drawn from the target population and information is obtained from this sample only once. Data Sources: Primary Source: Questionnaire is a structured technique for data collection that consists of a series of questions, written or verbal, that a respondent answers.

Research Instrument: A questionnaire is used as a data collection instrument for collecting the Primary data. A questionnaire consists of various questions in a structured format.

22

4.7.3) POPULATION DEFINITION : Population Sampling element labs Sampling unit Sampling frame Extent Time Non probability sampling technique : Judgemental sampling Sample size : Likert scale: 5-1/6=0.67 N = z2*62/D2 Z = 1.96 6 = 0.67 E = 0.138 N= (1.96)2*(0.67)2/ (0.138)2 N=90 Data analysis technique : Frequency Analysis Data analysis software Significance level : SPSS and Microsoft Excel. : 0.05 (95% confidence level is used where rejection rate is 5%) : A customer such as medical stores and path lab : Not available : In Ahmedabad. : May to June 2013 : All the customers such as medical stores and pathology labs. :All the customers in ahmedabad such as medical stores and pathology

23

CHAPTER 5 : DATA ANALYSIS

DATA ANALYSIS 1 :

5.1) For retail stores

1) Which companys syringe and needle you are keeping ?

TABLE-5.1.1

NAME Bd Nirlife health care Dispo Tiger get

RESPONSE 41 33 21 15

PERCENTAGE 41 % 33 % 21 % 15 %

CHART-5.1.1

45 40 35 30 25 20

41 33

21 15

15 10 5 0 Bd Nirlife health care Dispo Tiger get MARKET PRESENCE

24

Interpretation: There are 4 branded companys syringe and needle available in the market BD, NIRLIFE HEALTH CARE, DISPOVAN, TIGER GET . The market presence of BD is 37% , NIRLIFE HC is 30% , DISPOVAN is 19% , TIGER GET is 14% .

25

2) Why are you keeping that syringe and needle ?


TABLE-5.1.2

NAME

VARIABLE Bd_quality Bd_doctors prescribe

RESPONSE PERCENTAGE 19 10 10 02 10 17 5 1 8 6 4 1 4 5 3 3 19 % 10 % 10 % 02 % 10 % 17 % 5% 1% 8% 6% 4% 1% 4% 5% 3% 3%

Bd Bd_Material Bd_Services Nl_Quality Nl_Price Nirlife health care Nl_Material Nl_Services D_Quality D_Price Dispo D_Material D_Services Tg_Quality Tg_Price Tiger get Tg_Material Tg_Services

26

CHART-5.1.2 20 18 16 14 12 10 8 6 4 2 0
19 17

10

10

10 8 5 2 1 6 4 1 4 5 3 3

EFFECTIVE VARIABLE

Interpretation: BDs market presence is due to quality and is 19% , NIRLIFE HCs market presence is 17% and it is due to its low price and greater margin to retail stores , DISPOVANs market presence is 8% due to quality and TIGERGETs market presence is average in all criteria. In market BD is well known for its quality , NIRLIFE HC is known for its good margin and DISPOVAN is known for its quality and low price.

27

3) Which companys IVset you are keeping ?

TABLE-5.1.3

NAME B braun Nirlife health care Bd

RESPONSE 38 33 29

PERCENTAGE 38 % 33 % 29 %

CHART-5.1.3 40 35 30 25 20 15 10 5 0
38 33 29

B braun

Nirlife health care

Bd

MARKET PRESENCE OF IV SET

Interpretation: There are 3 companys iv set available in the market B BRAUN, NIRLIFE HC, BD. The market presence of B BRAUN is 38%, NIRLIFE HC is 33% and BD is 29% in iv set in retail stores. 4) Which companys diapers you are keeping ?
28

TABLE-5.1.4

NAME Sumo Nirlife health care Teddy baby Friends Puppy P/g

RESPONSE 25 14 14 16 09 20

PERCENTAGE 25 % 14 % 14 % 16 % 09 % 20 %

CHART-5.1.4

30
25

25
20

20
16

15 10 5 0

14

14 9

Sumo

Nirlife health Teddy baby care

Friends

Puppy

P/g

MARKET PRESENCE OF DIAPER

Interpretation: There are 6 companys adult diaper available in the market SUMO, NIRLIFE HC, TEDDY BABY, FRIENDS, PUPPY, P/G. There are 25% retail stores are keeping adult diaper of SUMO, 14% of NIRLIFE HC, 14% of TEDDY BABY, 16% of FRIENDS, 9% of PUPPY and 20% of P/G.

29

5) What do u think about consumption per month for syringes and needles ? a) Less than 20 c) 41-60 b) 21-40 d) Above 60
TABLE-5.1.5

NAME

VARIABLE Bd_Less than 20 Bd_21-40

RESPONSE PERCENTAGE 5 10 16 10 2 6 8 17 6 9 6 0 4 4 4 3 5% 10 % 16 % 10 % 2% 6% 8% 17 % 6% 9% 6% 0% 4% 4% 4% 3%

Bd

Bd_41-60 Bd_Above 60 Nl_Less than 20

Nirlife health care

Nl_21-40 Nl_41-60 Nl_Above 60 D_Less than 20 D_21-40

Dispo D_41-60 D_Above 60 Tg_Less than 20 Tg_21-40 Tiger get Tg_41-60 Tg_Above 60

30

CHART-5.1.5 18 16 16 14 12 10 10 8 8 6 6 4 2 2 0 5 4 4 4 3 6 6 10 9 17

CONSUMPTION

Interpretation: The BDs syringe and needle is selling highest in 41-60 quantity and is 16%, NIRLIFE HC is selling highest in >60 quantity and is 17%, DISPO is selling in 21-40 quantity is 9% and TG is selling average in all quantity.

31

6) what do u think about consumption per month for IV set ?

a) Less than 20 c) 41-60

b) 21-40 d) Above 60
TABLE-5.1.6

NAME

B braun

VARIABLE Bb_less than 20 Bb_21-40 Bb_41-60 Bb_Above 60 Nl_Less than 20 Nl_21-40 Nl_41-60 Nl_Above 60 Bd_Less than 20 Bd_21-40 Bd_41-60 Bd_Above 60

RESPONSE 4 16 17 3 4 7 12 10 3 6 12 8

PERCENTAGE 4% 16 % 17 % 3% 4% 7% 12 % 10 % 3% 6% 12 % 8%

Nirlife health care

Bd

CHART-5.1.6
17% 18% 16% 16% 14% 12% 12% 12% 10% 10% 8% 7% 8% 6% 6% 4% 4% 3% 3% 4% 2% 0%

CONSUMPTION OF IV SET

32

Interpretation: B BRAUN is selling highest in 41-60 quantity and is 17%, NIRLIFE HC is selling highest 12% in 41-60 % and BD is selling highest 12% in 41-60 quantity in retail stores

33

7) What do u think about consumption per month for diaper ? a) Less than 20 c) 41-60 b) 21-40 d) Above 60
TABLE-5.1.7

NAME

VARIABLE s_Less than 20 S_21-40 S_41-60 S_Above 60 Nl_Less than 20

RESPONSE 2 5 8 10 2 5 5 2 1 6 4 3 4 5 3 4 1 3 4 1 3 4 6 7

PERCENTAGE 2% 5% 8% 10 % 2% 5% 5% 2% 1% 6% 4% 3% 4% 5% 3% 4% 1% 3% 4% 1% 3% 4% 6% 7%

Sumo

Nirlife health care

Nl_21-40 Nl_41-60 Nl_Above 60 Tb_Less than 20

Teddy baby

Tb_21-40 Tb_41-60 Tb_Above 60 Fs_Less than 20

Friends

Fs_21-40 Fs_41-60 Fs_Above 60 Pp_Less than 20

Puppy

Pp_21-40 Pp_41-60 Pp_Above 60 Pg_Less than 20

p/g

Pg_21-40 Pg_41-60 Pg_Above 60

34 CHART-5.1.7

12

10

10

8
7 6 6 5 4 4 3 2 2 2 1 1 1 3 4 3 4 3 4

6
5 5 5

Interpretation: The SUMO is selling highest in >60 quantity and is 10%, NIRLIFE HC is selling highest in 21-40 and 41-60 quantity and is 5%, TEDDYBABY is selling highest as 6% in 21-40 quantity, FRIENDS is selling highest as 5% in 21-40 quantity, PUPPY is selling highest as 4% in 41-60 quantity and P/G is selling highest in >60 quantity and is 7% in retail stores.

S_less than 20 S_21-40 S_41-60 S_Above 60 Nl_Less than 20 Nl_21-40 Nl_41-60 Nl_Above 60 Tb_Less than 20 Tb_21-40 Tb_41-60 Tb_Above 60 Fs_Less than 20 Fs_21-40 Fs_41-60 Fs_Above 60 Pp_Less than 20 Pp_21-40 Pp_41-60 Pp_Above 60 Pg_Less than 20 Pg_21-40 Pg_41-60 Pg_Above 60 CONSUMPTION OF DIAPER

35

5.2) For path lab 1) Which companys syringe and needle you preffered ?

TABLE-5.2.1

NAME Bd Nirlife health care Dispo Tiger get

RESPONSE 28 48 14 10

PERCENTAGE 28 % 48 % 14 % 10 %

CHART-5.2.1 60 50 40 30 20 10 0
28 48

14 10

Bd

Nirlife health care

Dispo

Tiger get

MARKET PRESENCE

Interpretation: There are 4 branded companys syringe and needle available in the market BD, NIRLIFE HEALTH CARE, DISPOVAN, TIGER GET in pathology lab. The market presence of BD is 28 , NIRLIFE HC is 48% , DISPOVAN is 14% , TIGER GET is 10%.
36

2) Why you preffered that syringe and needle ?


TABLE-5.2.2

NAME

VARIABLE Bd_quality Bd_doctors prescribe

RESPONSE 12 6 5 5 10 21 8 9 5 4 4 1 1 3 5 1

PERCENTAGE 12 % 6% 5% 5% 10 % 21 % 8% 9% 5% 4% 4% 1% 1% 3% 5% 1%

Bd Bd_Material Bd_Services Nl_Quality Nirlife health care Nl_Price Nl_Material Nl_Services D_Quality D_Price Dispo D_Material D_Services Tg_Quality Tg_Price Tiger get Tg_Material Tg_Services

37

CHART-5.2.2 25
21

20 15 10
6 5 5 12 10 8 9 5 4 4 1 1 5 3 1

5 0

EFFECTIVE VARIABLE

Interpretation: BDs market presence is due to quality and is 12% , NIRLIFE HCs market presence is 21% and it is due to its low price and greater margin to Pathology lab , DISPOVANs market presence is 5% due to quality and TIGERGETs market presence is average in all criteria. In market BD is well known for its quality , NIRLIFE HC is known for its good margin and DISPOVAN is known for its quality and low price.

38

3) What do u think about consumption per month ? a) Less than 20 c) 41-60 b) 21-40 d) Above 60
TABLE-5.2.3

NAME

VARIABLE Bd_less than 20 Bd_21-40

RESPONSE 05 12 17 04 6 14 20 04 3 5 4 2 1 4 4 1

PERCENTAGE 05 % 12 % 17 % 04 % 6% 14 % 20 % 04 % 3% 5% 4% 2% 1% 4% 4% 1%

Bd Bd_41-60 Bd_Above 60 Nl_Less than 20 Nl_21-40 Nirlife health care Nl_41-60 Nl_Above 60 D_Less than 20 D_21-40 Dispo D_41-60 D_Above 60 Tg_Less than 20 Tg_21-40 Tiger get Tg_41-60 Tg_Above 60

39

CHART-5.2.3 25
20

20
17

15
12

14

10
5 6 4 4 3 5

4 2 1

4 1

CONSUMPTION

Interpretation: The BDs syringe and needle is selling highest in 41-60 quantity and is 17%, NIRLIFE HC is selling highest in 41-60 quantity and is 20%, DISPO is selling in 21-40 quantity is 5% and TG is selling average in all quantity.

40

4) Which ml and type of syringes you preffered ? Ml_______ and 2 pc 3 pc


TABLE-5.2.4

NAME 2 ml 5 ml 10 ml 20 ml

RESPONSE 20 54 22 4

PERCENTAGE NAME RESPONSE PERCENTAGE 20 % 2 pc 46 46 % 54 % 3 pc 54 54 % 22 % 04 %

CHART-5.2.4 60
54

50 40 30
20 22

20 10
4

5 ml

10 ml

20 ml

Interpretation: For the preference , 20% Pathology lab prefer 2 ml, 54% Pathology lab prefere 5 ml, 22% pathlab prefere 10 ml, 4% Pathology lab prefere 20 ml of syringe and needle .

41

CHART-5.2.5 56
54

54 52 50

48
46

46 44 42

2 pc

3 pc PREFERENCE

Interpretation: For the preference, 54% Pathology lab prefer 3 pc and 46% Pathology lab prefer 2 pc syringe and needle. So syringe and needle contain rubber gasket is widely used in pathology lab.

42

DATA ANALYSIS 2:

5.3) MICROSOFT EXCEL


TABLE-5.3.1.1

RATAIL STORES
Name of RS Sanjay Medical Stores Anand Medical Stores Sunrice Chemist Om Medical Stores Shayam Pharmacy Sarthak Medical Stores Paras Ayurvedic Stores Silver Medicines Shanti Medical Stores Zalak Medivcal Stores Banshari Medical Stores Paras Medical Stores Raj Chemist Medilink Medical Stores Apollo Pharmacy Yash Stores Vijay Stores Manan Stores S/N
DISPO DISPO NL bd BD TG TG TG dispo DISPO NL NL NL NL NL DISPO TG TG

Sales
41-60 21-40 >60 41-60 21-40 >60 41-60 21-40 >60 41-60 21-40 >60 41-60 21-40 >60 41-60 21-40 >60

Iv set
NL NL NL B BRAUN B BRAUN NL NL NL BD BD B BRAUN B BRAUN B BRAUN B BRAUN B BRAUN BD NL NL

Sales
>60 >60 41-60 21-40 41-60 21-40 >60 41-60 21-40 >60 41-60 21-40 >60 41-60 21-40 >60 41-60 21-40

Diaper
SUMO SUMO FRIENDS FRIENDS

Sales
20< 21-40 20< 21-40

TEDDYBABY 20< SUMO SUMO PUPPY P/G P/G NL FRIENDS SUMO friends 21-40 20< 20< 21-40 20< 21-40 20< 21-40 20<

TEDDYBABY 21-40 NL sumo NL 20< 21-40 20< 43

Prakash Ayurvedic Stores Paras Pharmacy Gayatri Medical Stores Shreeji Medical Stores Arpan Chemists Drashti Clinic Mudra Medicines Tapan Medical Stores Jalaram Medical Stores Natraj Medical Stores Karishna Medical Stores Maruti Medical Stores Dhara Medical Stores Sagar Medical Stores Mahavir Medical Stores Umiya Medical Stores Patel Medical Stores Dev Medical Stores Ghanshayam Medical Stores Mahavir Medical Stores

DISPO

41-60

NL NL B BRAUN B BRAUN B BRAUN B BRAUN B BRAUN B BRAUN NL NL NL NL NL NL BD NL NL NL NL B BRAUN

>60 41-60 21-40 >60 41-60 21-40 >60 41-60 21-40 >60 41-60 21-40 >60 41-60 21-40 >60 41-60 21-40 >60 41-60

TEDDYBABY 21-40 FRIENDS P/G P/G P/G P/G P/G P/G SUMO SUMO SUMO SUMO SUMO SUMO PUPPY NL PUPPY 20< 21-40 20< 21-40 20< 21-40 20< 21-40 20< 21-40 20< 21-40 20< 21-40 20< 21-40

DISPO/NL 21-40 BD BD BD BD NL BD NL TG DISPO TG NL DISPO TG NL DISPO NL NL BD >60 41-60 21-40 >60 41-60 21-40 >60 41-60 21-40 >60 41-60 21-40 >60 41-60 21-40 >60 41-60 21-40

TEDDYBABY 20< TEDDYBABY 21-40 P/G 20<

44

Anuradha Medical Stores Chirag Medical Stores Nirmal Medical Stores Kuldeep Medical Stores Rajdeep Stores Karnavati Medical Stores Jagdish Medical Stores Pated Medical Stores Parth Chemist Jalaram Medicine Navdeep Medical Stores Narayan Medical Stores Rajasthan Medical Stores Radhe Medical Stores Hiren Drugist Abhinav Pharma A One Medical Stores Hardik Medical Stores Shree Ganesh Medical Stores Raj Medical Saurashtra Medical Stores Mahavir Medical

BD NL BD BD NL DISPO BD DISPO BD BD NL TG BD BD NL BD TG DISPO TD NL TG DISPO

>60 41-60 21-40 >60 41-60 21-40 >60 41-60 21-40 >60 21-40 41-60 21-40 >60 41-60 >60 41-60 21-40 >60 41-60 41-60 >60

NL NL B BRAUN BD BD BD BD BD BD BD B BRAUN NL BD BD B BRAUN BD BD BD BD BD BD BD

21-40 >60 41-60 21-40 >60 41-60 21-40 >60 41-60 21-40 41-60 >60 21-40 41-60 21-40 41-60 21-40 >60 41-60 20< 21-40 41-60

FRIENDS

21-40

TEDDYBABY 20< NL P/G P/G P/G P/G P/G P/G P/G PUPPY FRIENDS P/G P/G P/G SUMO P/G P/G 21-40 20< 21-40 20< 21-40 20< 21-40 20< 21-40 20< 21-40 20< 21-40 20< 21-40 20<

TEDDYBABY 21-40 FRIENDS FRIENDS PUPPY 20< 21-40 20< 45

Stores Sagar Medical Stores Karishna Chemist Darshan Drugist Priyank Medical Stores Kakdiya Medical Stores Yash Medical Stores Param Chemist Kaham Medical Stores Aum Pharmacy Unjha Pharmacy Dwarkesh Chemist Shreeji Medical Stores Abc Medicines Dhyani Stores Sagar Stores Akshar Simandhar Medical Stores Mahakali Medicines Nirman Medicines Shyam Medical Gaurav Medicines Navjyot Medical
BD BD 41-60 21-40 BD NL B BRAUN NL B BRAUN BD BD B BRAUN B BRAUN NL B BRAUN NL B BRAUN NL B BRAUN NL B BRAUN NL B BRAUN B BRAUN BD BD 21-40 >60 41-60 21-40 >60 41-60 >60 21-40 21-40 41-60 21-40 41-60 21-40 41-60 21-40 >60 >60 21-40 >60 20< >60 41-60 TEDDYBABY 21-40 FRIENDS NL SUMO 20< 21-40 20<

NL/DISPO >60 NL NL NL BD BD DISPO NL BD/NL NL BD NL BD BD BD BD NL NL BD NL 41-60 21-40 >60 41-60 >60 21-40 >60 41-60 >60 >60 >60 >60 41-60 >60 41-60 >60 21-40 41-60 21-40

TEDDYBABY 21-40 PUPPY FRIENDS NL PUPPY SUMO FRIENDS SUMO NL PUPPY SUMO SUMO 20< 21-40 >60 21-40 20< 21-40 21-40 21-40 20< 20< 20<

TEDDYBABY 21-40 SUMO FRIENDS SUMO P/G P/G 20< 21-40 20< 20< 21-40 46

Stores Rajdeep Medical Stores Nirmman Medical Stores Ram Chemist Janak Medical Stores Dhanvantari Medical Stores Ghanshayam Medical Stores Drashti Medical Stores Paras pharmacy
BD NL TG BD NL DISPO NL BD >60 21-40 41-60 41-60 >60 21-40 >60 41-60 BD B BRAUN NL BD B BRAUN B BRAUN BD B BRAUN 21-40 41-60 >60 >60 21-40 21-40 41-60 21-40 P/G PUPPY FRIENDS FRIENDS NL PUPPY SUMO FRIENDS 20< 21-40 20< 21-40 >60 21-40 20< 21-40

Calculation: Syringe Needle


SUM OF ALL NL AVRG FLOW NL % LOW 3797 1378 42 36 HIGH 4800 1720 54 35

TABLE-5.3.1.1

Iv set
SUM OF ALL NL AVRG FLOW NL % LOW HIGH 3521 1358 39 39 4680 1700 52 36 SUM OF ALL NL AVRG FLOW NL %

Diaper
LOW 1924 264 21 14 HIGH 2760 340 31 12

Interpretation: From the calculation of excel data sheet , the market share of NIRLIFE HC is found to be 35.5 % in syringe and needle in retail stores. From the calculation of excel sheet data , the market share of NIRLIFE HC is found to be 37.5 % in iv set in retail stores.

47

From the calculation of excel sheet data , the market share of NIRLIFE HC is found to be 13 % in diaper in retail stores.

PATHOLOGY LAB Name of PL Bhagyoday Shreeji Astha Kacchadiya Radhe Divine Hardik Adarsh Bilani Medi Care Milan Patel Ronak Kedar Prem Ram Bajaj Dev Gayatri Sivam Bharat Sanjeevani Bhagyashri Dhruti Dhanvantari Place Bapunagar Bapunagar Bapunagar Bapunagar Bapunagar Bapunagar Bapunagar Bapunagar Naroda Naroda Naroda Naroda Naroda Naroda Naroda Naroda Naroda Naroda Naroda Naroda Naroda Naroda Naroda Maninagar Maninagar S/N NL NL BD NL NL BD NL DISPO NL/DISPO NL NL NL TG NL BD NL NL NL NL TG TG BD TG NL NL Sales >60 41-60 21-40 20< >60 41-60 21-40 20< 20< 21-40 41-60 >60 20< 21-40 41-60 >60 41-60 21-40 20< >60 41-60 21-40 20< >60 20<
48

Shivam Shalam Kashyap Scientific Gold Coin Reliable Sigma Parsva Jeevandeep Giriraj Shradha Vraj Sun Symmers Shubham Rushabh Suuvidha Balaji Aarambh Shree Shubham Vrundavan Shubh Lakshmi Ankur Pathocare Astha Akshar Manan Navkar Milan Sivam Bajaj Ram Sanjivani Darpan

Maninagar Maninagar Maninagar Satellite Satellite Satellite Satellite Satellite Satellite Satellite Satellite Satellite Satellite Satellite Satellite Satellite Satellite Naranpura Naranpura Naranpura Naranpura Naranpura Naranpura Thakkerbapanagar Karishnanagar Karishnanagar Karishnanagar Karishnanagar Karishnanagar Karishnanagar Karishnanagar Vadaj Vadaj

BD NL DISPO NL NL TG NL TG TG NL DISPO/NL NL DISPO NL NL NL DISPO NL DISPO NL DISPO BD NL NL NL BD NL BD BD NL BD NL NL

21-40 41-60 >60 >60 41-60 21-40 20< >60 41-60 20< >60 41-60 21-40 20< >60 41-60 >60 41-60 21-40 20< >60 21-40 20< 20< >60 41-60 21-40 20< >60 41-60 21-40 20< >60
49

Shilp Vadaj Mahakant Sarthak Raj Nishant Mukti Parth Krishna Sarthak Ranip Ganshyam Shivam Home Care Satyam Vrundavan Medicare Diagnostics

Vadaj Vadaj Vadaj Vadaj Vadaj Vadaj Vadaj Vadaj Vadaj Vadaj Vadaj Vadaj Vadaj Vadaj Vadaj Vadaj Vadaj

NL NL BD NL NL NL BD BD NL NL NL BD NL BD BD NL BD

41-60 21-40 20< >60 21-40 >60 >60 41-60 21-40 20< 41-60 20< 41-60 41-60 >60 41-60 21-40

Calculation:

TABLE-5.3.2.2

SYRINGE - NEEDLE SUM OF ALL NL LOW 2377 1361 MARKET SHARE NL 43.52 44.79 HIGH 2240 1320

Interpretation:
From the calculation of excel data sheet , the market share of NIRLIFE HC is found to be 44%, in syringe and needle in Pathology lab.
50

DATA ANALYSIS 3 :

5.4) CHI-SQUARE TEST

5.4.1) Preference and consumption of syringe and needle at retail store H0 : There is no association between preference of syringe/needle and consumption of syringe/needle at retail stores . H1 : There is association between preference of syringe/needle and consumption of syringe/needle at retail stores.
TABLE-5.4.1.1

Syringe/needle*consumption consumption Observed N 21-40 42-60 >60 Total 26 31 33 90 Expected N 30.0 30.0 30.0 Residual -4.0 1.0 3.0

TABLE-5.4.1.2

Chi-square test consumption Chi-Square Df Asymp. Sig. Sig. Monte Carlo Sig. Lower Bound Upper Bound .867a 2 .648 .722b .630 .815

95% Confidence Interval

51

Interpretation:
Here significance value is greater than 0.05 so I accept H0 null hypothesis so, There is no association between preference of syringe/needle and consumption of syringe/needle at retail stores .

5.4.2) Preference and consumption of IV set at retail stores H0: There is no association between preference of IV set and consumption of IV set . H1 : There is association between preference of IV set and consumption of IV set.

TABLE-5.4.2.1

IV set *consumption Consumption Observed N 20< 21-40 42-60 >60 Total 2 32 29 27 90 Expected N 22.5 22.5 22.5 22.5 Residual -20.5 9.5 6.5 4.5

52

TABLE-5.4.1.2

Test Statistics consumption Chi-Square Df Asymp. Sig. Sig. Monte Carlo Sig. Lower Bound Upper Bound 25.467a 3 .000 .000b .000 .025

90% Confidence Interval

Interpretation:
Here significance value is less than 0.05 so i reject H0 null hypothesis and accept H1 so, There is some association between preference of Iv set and consumption of Iv set.

5.4.3) Preference and consumption of Diaper at retail stores H0: There is no association between preference of Diaper and consumption of Diaper. H1 : There is association between preference of Diaper and consumption of Diaper.

53

TABLE-5.4.3.1

Diaper*consumption Consumption Observed N 20< 21-40 >60 Total 44 44 2 90 Expected N 30.0 30.0 30.0 Residual 14.0 14.0 -28.0

TABLE-5.4.3.2

Test Statistics consumption Chi-Square Df Asymp. Sig. Sig. Monte Carlo Sig. Lower Bound Upper Bound 39.200a 2 .000 .000b .000 .025

90% Confidence Interval

Interpretation:
Here significance value is less than 0.05 so I reject H0 null hypothesis and accept H1 so, there is some association between preference of diaper and consumption of diaper.

54

5.4.4) Preference and consumption of syringe/Needle at Pathology lab H0: There is no association between preference of syringe/Needle and consumption of syringe/Needle at Pathology lab. H1 : There is association between preference of syringe/Needle and consumption of syringe/Needle at Pathology lab.
TABLE-5.4.4.1

Syringe/Needle *consumption consumption Observed N 20< 21-40 41-60 >60 Total 18 17 20 20 75 Expected N 18.8 18.8 18.8 18.8 Residual -.8 -1.8 1.3 1.3

TABLE-5.4.4.2

Test Statistics consumption Chi-Square Df Asymp. Sig. Sig. Monte Carlo Sig. Lower Bound Upper Bound .360a 3 .948 .947b .904 .989

90% Confidence Interval

55

Interpretation:
Here significance value is greater than 0.05 so I accept H0 null hypothesis so, There is no association between preference of syringe/needle and consumption of syringe/needle at path lab.

56

CHAPTER 6 : FINDING OF THE STUDY

From conducting this research, I found thet 1) There are large number of syringe and needle used in India. For syringe and needle, there are two type of market 1) local market, 2) branded market. Around 10-15 % is goes to local market and 85-90 % is goes to Branded market for syringe and needle. Most of syringe and needle are consumed due to doctors preference to the Branded syringe and needle. 2) 2) In Pathology lab syringe and needle used which is more profitable, good in quality and available in large range of size is preferable. 3) For the IV set, now a day a consumption of Branded is more. For the diaper there is equal market for both local as well as Branded. There is preference of consumer so that there is large number of variable affect it. There is large number of companies in diaper manufacturer.

LIMITATION Although this research project was carefully prepared by me, I am still aware of its limitations and shortcomings. The research was conducted in the month of May-June, so there is less chance of diseases compare to monsoon and winter. The respondent (chemist) did not give their response properly. The time was also a limited constraint for this project because there are so many retail medical stores are left which cause greater result in this project. It would be better if it was done in a longer time. So data may vary from time to time.

57

RECOMMANDATION

I recommend from this project that Nirlife deserve good market share , good repo, good will in the market. From my this research, I suggest that 1) Nirlifes product is sold due to good margin to retail stores and Pathology lab but they should increase the quality as BD to increase the sales and to increase the market share. There are so many retail medical stores are found in which keeps unknown brand of syringe and needle which covered some profitable market share. They were cheaper in price and give the same result as other branded creams.

58

CHAPTER 7 : CONCLUSION

Primary data was collected through questionnaires by asking respondents to rate the variables as per their preference for syringe/needle, IV set, diaper. From the analysis of data, I conclude that market presence of Nirlife health care is 33 retail stores out of 90. It seems to be good and market presence of Nirlife health care is 40 path labs out of 75. For IV set market presence is 33 out of 90 and for diaper market presence is 13 out of 90. From ms-excel calculation, I conclude that market share of syringe and needle is 35.5 %, for IV set is 37.5 % and for diaper is 13 % in retail stores. For syringe and needle in Pathology lab, Nirlife cantains 44 % market share.

59

ANNEXURE

Questionnaire For retail stores

I am a student of MBA (pharmaceuticals) at CENTRE FOR MANAGEMENT STUDIES, GANPAT UNIVERSITY. The following questionnaire contains some of the objective questions and same is the part of my research work of the In-depth study of market share and market presence of MDD product with reference to Nirlife health care pvt ltd. Kindly mark the blanks that best indicates how they would describe the object being rated.

(FOR RS, MDD PRODUCTS NIRLIFE, AND MARKET SURVEY) Drug store Name: Area:

1. Which companys syringe and needle you are keeping? _____________________ And/or___________________.

2. Why are you keeping that syringe and needle ? ______________________________________. 3. Which companys IVset you are keeping? _________________and/or________________. 4. Which companys diapers you are keeping? _________________and/or________________.

60

5. What do u think about consumption per month for syringes and needles?

a) Less than 20 c) 41-60

b) 21-40 d) Above 60

6. What do u think about consumption per month for IV set?

a) Less than 20 c) 41-60

b) 21-40 d) Above 60

7. What do u think about consumption per month for diaper?

a) Less than 20 c) 41-60

b) 21-40 d) Above 60

THANK YOU

61

QUESTIONNAIRE FOR PATHLAB

I am a student of MBA (pharmaceuticals) at CENTRE FOR MANAGEMENT STUDIES, GANPAT UNIVERSITY. The following questionnaire contains some of the objective questions and same is the part of my research work of the topic market share and market presence of MDD product with reference to Nirlife health care pvt ltd Kindly mark the blanks that best indicates how they would describe the object being rated.

(for pl , mdd products Nirlife , market survey)

NAME: AREA: NAME OF PERSON:

1. Which companys syringe and needle you preffered? _____________________.

2. Why you preffered that syringe and needle ? ___________________________________________ .

3. What do u think about consumption per month?

a) Less than 20 c) 41-60

b) 21-40 d) Above 60

62

4. Which ml and type of syringes you preffered? Ml_______ and 2 pc 3 pc 5. Which criteria is most important for selection of syringe and needle ? Service Quality price margin

THANK YOU

63

BIBLIOG RAPHY

a. Kotler, Armstrong. Principles of Marketing Pearson education, 2011. b. Malhotra, Dash. Marketing Research, Prentice Hall, 2010. c. Manav kataria, viral thakar (2010), B plan retractable and auto disable syringe, as appeared in proquest.com/india/market research downloaded on date-20/05/2013 d. Rumana Anjuman Ara,(2012), Report On Business Marketing (Course: 514) Topic: Business Marketing Research on JMI, a B2B Market, Section: A Department of Marketing (14 th),Faculty of Business Studies , University of Dhaka. Vol. 11 No. 1, pp. 18-28. e. Nirma Group Limited,Nirlife health care pvt ltd,2008-2013, e-mail:

nirlifehealthcare@nirma.co.in, Nirlifehealthcare.in.

64